PPH
PPH
About VanEck Pharmaceutical ETF
VanEck Pharmaceutical ETF (PPH) seeks to replicate as closely as possible, before fees and expenses, the price and yield performance of the MVIS US Listed Pharmaceutical 25 Index (MVPPHTR), which is intended to track the overall performance of companies involved in pharmaceuticals, including pharmaceutical research and development as well a production, marketing and sales of pharmaceuticals.
About VanEck Pharmaceutical ETF
VanEck Pharmaceutical ETF (PPH) seeks to replicate as closely as possible, before fees and expenses, the price and yield performance of the MVIS US Listed Pharmaceutical 25 Index (MVPPHTR), which is intended to track the overall performance of companies involved in pharmaceuticals, including pharmaceutical research and development as well a production, marketing and sales of pharmaceuticals.
HOLDINGS (Top 20)
| Stock | Name | Weight | Shares | Market Value |
|---|---|---|---|---|
 LLY | Eli Lilly and Company | 18.87% | 208.33K | $193.65M |
 NVS | Novartis AG | 10.92% | 725.57K | $112.08M |
 MRK | Merck & Co., Inc. | 9.71% | 828.74K | $99.57M |
 PFE | Pfizer Inc. | 5.08% | 1.91M | $52.15M |
 NVO | Novo Nordisk A/S | 4.96% | 1.34M | $50.93M |
 GSK | GSK plc | 4.91% | 854.09K | $50.34M |
 SNY | Sanofi | 4.60% | 1.01M | $47.22M |
 BMY | Bristol-Myers Squibb Company | 4.44% | 785.34K | $45.60M |
 MCK | McKesson Corporation | 4.25% | 50.41K | $43.59M |
 JNJ | Johnson & Johnson | 4.24% | 182.76K | $43.49M |
 ABBV | AbbVie Inc. | 3.91% | 194.08K | $40.07M |
 COR | Cencora, Inc. | 3.79% | 121.87K | $38.89M |
 ZTS | Zoetis Inc. | 3.53% | 301.20K | $36.17M |
 HLN | Haleon plc | 3.16% | 3.29M | $32.38M |
 TAK | Takeda Pharmaceutical Company Limited | 3.02% | 1.74M | $31.03M |
 TEVA | Teva Pharmaceutical Industries Limited | 2.92% | 962.75K | $29.99M |
 VTRS | Viatris Inc. | 0.92% | 681.27K | $9.42M |
 JAZZ | Jazz Pharmaceuticals plc | 0.83% | 43.41K | $8.48M |
 AXSM | Axsome Therapeutics, Inc. | 0.54% | 31.16K | $5.56M |
 ELAN | Elanco Animal Health Incorporated | 0.35% | 151.40K | $3.61M |
SECTOR HOLDINGS
HealthcareASSET ALLOCATION BY REGION
United States
United Kingdom
Switzerland
Denmark
France
Japan
Israel
Ireland
CanadaSECTOR HOLDINGS
HealthcareASSET ALLOCATION BY REGION
United States United Kingdom Switzerland Denmark France Japan Israel Ireland CanadaHoldings (Top 20)
LLY
Eli Lilly and Company
NVS
Novartis AG
MRK
Merck & Co., Inc.
PFE
Pfizer Inc.
NVO
Novo Nordisk A/S
GSK
GSK plc
SNY
Sanofi
BMY
Bristol-Myers Squibb Company
MCK
McKesson Corporation
JNJ
Johnson & Johnson
ABBV
AbbVie Inc.
COR
Cencora, Inc.
ZTS
Zoetis Inc.
HLN
Haleon plc
TAK
Takeda Pharmaceutical Company Limited
TEVA
Teva Pharmaceutical Industries Limited
VTRS
Viatris Inc.
JAZZ
Jazz Pharmaceuticals plc
AXSM
Axsome Therapeutics, Inc.
ELAN
Elanco Animal Health Incorporated